Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristen Swift
Institution:
Levine Cancer Institute
Observed institution:
Levine Cancer Institute
ORCID:
0009-0002-3235-8253
Observed ORCID:
0009-0002-3235-8253
OpenAlex ID:
A5068290191
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase ( DPYD ) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center
2024
·
D. Grace Nguyen
, Sarah A. Morris
, et al.
·
JCO Precision Oncology
·
23
Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center
2023
·
Sarah A Morris
, Donald C Moore
, et al.
·
American Journal of Health-System Pharmacy
·
15
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma
2019
·
Hailey Hill
, Justin Arnall
, et al.
·
Journal of Oncology Pharmacy Practice
·
2
Real-world experience of an in-house dihydropyrimidine dehydrogenase (DPYD) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital.
2023
·
Jai Narendra Patel
, Sarah Morris
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
4
Citation count:
41
H-index:
2
I10-index:
2
Year
Topic
Type